<DOC>
	<DOC>NCT01222650</DOC>
	<brief_summary>The objective of this study is to evaluate the efficacy and safety of KSO-0400 compared to placebo for the treatment of LUTS caused by BPH.</brief_summary>
	<brief_title>A Comparative Study of KSO-0400 in BPH Patients With LUTS</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Silodosin</mesh_term>
	<criteria>BPH patients with LUTS Patients with a history of prostatectomy, intrapelvic radiation therapy, thermotherapy of prostate or prostatic hyperthermia Patients with prostate cancer or suspected prostate cancer Patients who have any clinically relevant cardiovascular, hepatic or renal disorder</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Benign Prostatic Hyperplasia</keyword>
	<keyword>I-PSS</keyword>
	<keyword>Î±1A-AR antagonist</keyword>
</DOC>